News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sun Pharmaceutical Industries Ltd May Get Windfall Gains on Cancer Drug Doxil


9/26/2013 7:49:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

One loss might be another one’s gain and that is applicable for Sun Pharma today. The stock is up on news that the company might reap windfall gains on one of its US drugs Doxil generic used for cancer. Reason being, Johnson and Johnson the innovator of Doxil is facing supply disruptions due to production issues at Ben Venue, its manufacturing partner.

Help employers find you! Check out all the jobs and post your resume.

Read at Money Control
Read at EconomicTimes


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES